Casey Tansey

Casey Tansey

Signal active

General Partner

Bio

Casey Tansey joined USVP as a general partner in April 2005. A veteran of the medical device industry, Casey brings over 25 years of entrepreneurial, early-stage medical device and seasoned operating experience to USVP.

Casey's extensive operations experience brings more to the table than strategic counsel -- he adds empathy to that mix.

Casey's investment strategy is a lot like his strategy as a CEO: identify unmet clinical needs where patients are in need of new and improved products and services. At USVP, Casey focuses on the trend toward the miniaturization of devices and the development of minimally-invasive technologies that promise innovations in the delivery of medical products and services, especially in cardiovascular products, orthopedics, spinal care and neurology.

Casey's passion is to strive for delivery of medical services with less trauma to the patient and improved quality of life. Innovations shaping this trend include minimally-invasive technologies. During his tenure as CEO and President of Epicor Medical from 2001 to 2004, Casey, along with a dedicated team, pioneered a minimally-invasive treatment for atrial fibrillation and transformed the company into a recognized market leader, and he led Epicor's acquisition by St. Jude Medical.

Prior to Epicor, Casey was CEO and President of Heartport, a public company that helped pioneer minimally-invasive cardiac surgery which is now a Johnson & Johnson company. Before that, he was with Baxter Edward's Cardiovascular Division for nearly ten years, holding various sales and marketing positions. During his tenure at Baxter, Casey was involved in launching innovative heart valve products that have grown to be the market leaders.

Casey serves on the Board of Directors for ApniCure, CardioKinetix, Devax, Inspire Medical, Intersect ENT, Intuity Medical, ReShape Medical, and SentreHEART.

In addition, he served as the Chairman of the Board of Directors of the World Heart Foundation, an organization dedicated to advancing humanitarian efforts in heart surgery worldwide through education and collaboration.

Casey holds a B.S. and M.B.A. from the College of Notre Dame in Belmont, CA.

Casey has served on the boards of Epicor Medical and Heartport.

Location

Menlo Park, California, United States, North America

Social

N/A

Primary Organization

U.S. Venture Partners

U.S. Venture Partners

Founded

1981

Investment

577

Lead investment

175

Exits

158

Employees

11-50

Industry

Enterprise Software, Financial Services, Venture Capital

Jobs history

2

Luminopia

Board of Director

Invalid date - Current

MicroTransponder

Board Member

Invalid date - Current

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Casey Tansey is the General Partner at U.S. Venture Partners, based in United States, North America. With a background in Enterprise Software, Casey Tansey has a rich history of leadership and innovation. Casey Tansey studied BS unknown @ University of Notre Dame. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Investment portfolio

N/A

Number of investment

1

Number of exits

0

Personal investment

0

There is no personal investment available on this profile

Partner investment

14

Annouced DateOrganization NameFunding RoundInvestor NameMoney Raised
Jun 01, 2021
Standard Bariatrics Standard Bariatrics
Series B - Standard Bariatrics
Standard Bariatrics U.S. Venture Partners
35.0M
Jun 20, 2022
MicroTransponder MicroTransponder
Series E - MicroTransponder
MicroTransponder U.S. Venture Partners
73.0M
Jun 27, 2023
Luminopia Luminopia
Series A - Luminopia
Luminopia U.S. Venture Partners
16.0M
Feb 20, 2024
Cagent Vascular Cagent Vascular
Series C - Cagent Vascular
Cagent Vascular U.S. Venture Partners
30.0M

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity

There is no recent news or activity for this profile.